Lev Pharmaceuticals Inc

Premium Company Profile

Publication Date	April 2008
Publisher	Datamonitor
Product Type	Report
Pages	34
ISBN Number	not applicable
Product Code	DAT11501

Price

£265.00
approximately: $521 | €337

PDF

PRINT £315 ($619 | €400)

Order above formats by FAX

Summary

Introduction

Lev Pharmaceuticals is a development stage biopharmaceutical company engaged in developing and commercializing therapeutics based on C1-esterase inhibitor (C1-INH) for the treatment of inflammatory diseases. Cinryze, the company's lead drug candidate, is being developed for acute and prophylactic treatment of hereditary angioedema (HAE).

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Lev Pharmaceuticals in-licensed C1-INH from Sanquin in 2004. C1-INH is a human plasma protein that mediates inflammation and coagulation. Besides the current pipeline candidates, Lev Pharmaceuticals is also studying the use of C1-INH in the treatment of other inflammation-linked diseases such as gram-negative septicemia, inflammatory bowel disease, Alzheimer's disease and stroke. The company did not record revenues during the period 2002-2006 because the company currently does market any products, and has no other source of revenues. Lev Pharmaceuticals forecasts to derive 100% of its revenues from the sales of Cinryze. The total revenues will grow from $43 million in 2008 to $143 million in 2010.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization .

Content

Overview
Catalyst
Summary
- Table of Figures
- Table of Tables
- Company Structure
- Company Overview and Key Facts
- Business Description
- Landmark Products and Services
- C1-Inh Technology
- History
- Company Financials
- Stock Market Performance
- P&l
- Balance Sheet
- Cash Flow
- Products & Services
- Pipeline Products
- in-House Pipeline
- Cinryze
- C1-Inh
- Ac Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Shareholding Structure
- Strategy
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- C1-Inh Technology
- Weaknesses
- Inability to Raise Additional Funds in Capital Markets
- Opportunities
- Cinryze
- Additional Indication of C1-Inh
- Threats
- Hurdles in Launching Cinryze
- Uncertainty over Market Acceptance
- Value Chain Analysis
- Overview
- Product Development
- Sales
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Joshua D Schein
- Judson Cooper
- Henry M Dachowitz
- Scott Eagle
- Thomas Lanier
- Eric I Richman
- Douglas J Beck
- Matt Duffy
- Jason Bablak
- Bart Jones
- Ira N Kalfus
- Joseph Truitt
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
List of Tables
- Table 1: Lev Pharmaceuticals- Key Facts
- Table 2: Lev Pharmaceuticals- Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 3: Lev Pharmaceuticals- Key Events Impacting Share Price Performance
- Table 4: Lev Pharmaceuticals- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 5: Lev Pharmaceuticals- Balance Sheet
- Table 6: Lev Pharmaceuticals- Cash Flow
- Table 7: Lev Pharmaceuticals- in-House Pipeline Products
- Table 8: Lev Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
- Table 9: Lev Pharmaceuticals- Key Competitors
- Table 10: Lev Pharmaceuticals- Key Suppliers
- Table 11: Lev Pharmaceuticals- Key Shareholders
- Table 12: Lev Pharmaceuticals- SWOT Analysis Summary
- Table 13: Lev Pharmaceuticals- Value Chain Analysis
- Table 14: Lev Pharmaceuticals- Key Employees
- Table 15: Lev Pharmaceuticals - Financial and Operational Overview
List of Figures
- Figure 1: Lev Pharmaceuticals- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)